Vaccine Effectiveness against SARS-CoV-2 Variant P.1 in Nursing-Facility Residents, Washington, USA, April 2021

Details

• Alternative Title:
  Emerg Infect Dis
• Personal Author:
  Lewis, James W. ; Loughran, Julie ; Deng, Li ; Varghese, Jasmine ; Clark, Shauna ; Harrison, Casandra ; Gacetta, Molly ; Jernigan, John A. ; Fleming-Dutra, Katherine E.
• Description:
  A SARS-CoV-2 P.1 (Gamma) variant outbreak occurred at a skilled nursing facility in Washington, USA, in April 2021. Effectiveness of 2 doses of mRNA vaccines against P.1 infection among residents in this outbreak was 75.0% (95% CI 44.5%-88.7%), similar to effectiveness for other pre-Delta variants among long-term care residents.
• Subjects:
  Coronavirus Disease COVID-19 Humans Long-Term Care P.1 Respiratory Infections SARS-COV-2 Severe Acute Respiratory Syndrome Coronavirus 2 United States Vaccine Effectiveness Vaccine Effectiveness Against SARS-COV-2 Variant P.1 In Nursing-Facility Residents, , Usa, April 2021 Vaccine Efficacy Viruses Washington Zoonoses

  More +
• Source:
  Emerg Infect Dis. 2022; 28(11):2338-2341
• Pubmed ID:
  36170764
• Pubmed Central ID:
  PMC9622236
• Document Type:
  Journal Article
• Genre:
  Letter
• Place as Subject:
  Washington
• Volume:
  28
• Issue:
  11
• Collection(s):
  Emerging Infectious Diseases
• Main Document Checksum:
  urn:sha256:40e90b451423dca5d7bc9ecbfec224333fd61d5d7833f132d18e0236732d8101
• Download URL:
  https://stacks.cdc.gov/view/cdc/122132/cdc_122132_DS1.pdf
• File Type:
  [PDF - 333.13 KB ]